SDPA Webinar: Beyond the Black Box: Understanding Cardiovascular Risk with JAK Inhibitors
Includes a Live Web Event on 07/15/2026 at 8:00 PM (EDT)
-
Register
- Non-member - $50
- Affiliate - Free!
- Diplomate Fellow - Free!
- Fellow- Diplomate - Free!
- Student - Free!
- Fellow - Free!
- Associate - Free!
- Physician - Free!
- Diplomate Associate - Free!
- Diplomate Affiliate - Free!
- Diplomate Student - Free!
- Diplomate Physician - Free!
- DermNP - Free!
- Diplomate DermNP - Free!
- International DermPA - Free!
- Diplomate International DermPA - Free!
Join SDPA and Jason F. Goldberg, MD, MS, FAAP, FACC on Wednesday, July 15 at 8:00pm!
JAK inhibitors have transformed the treatment of inflammatory skin disease but have also raised concerns regarding cardiovascular and thrombotic risk. This 60-minute webinar will review the biologic basis of JAK inhibition, examines the evidence that led to current FDA boxed warnings, and provides a practical approach to cardiovascular risk assessment and patient counseling in everyday dermatology practice. Dr. Goldberg will be joined by guest speaker, Laura Bush, DMSc, PA-C, DFAAPA to provide a DermPA perspective!
Participants will:
- Review immune pathways and their relevance to major adverse cardiac events (MACE) and venous thromboembolism (VTE) risk
- Explain the evidence and rationale underlying the FDA boxed warning for JAK inhibitors.
- Evaluate available data regarding cardiovascular safety outcomes among JAK inhibitors and related immunomodulatory therapies used in dermatology.
- Recognize clinical scenarios in which further cardiovascular evaluation or consultation may be appropriate in the development of shared decision-making with patients.
This activity has been reviewed by the American Academy of Physician Associates Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. Approval is valid from 7/15/2026 to 7/15/2026. AAPA reference number: CME-2015899.
Jason F. Goldberg, MD, MS, FAAP, FACC
Medical Director of Heart Failure and Pediatric Research
Inova Children's Hospital
Jason F. Goldberg, MD, MS, FAAP, FACC is a cardiologist and physician-scientist with expertise in advanced heart failure, transplantation, and genomics. He serves as Medical Director of Heart Failure and Pediatric Research at Inova Children's Hospital. His research focuses on novel omics-based diagnostics, bridging translational science and clinical medicine, with a particular interest in how immune and inflammatory pathways influence cardiovascular disease and therapeutic outcomes.
Laura Bush, DMSc, PA-C, DFAAPA
Laura Bush, DMSc, PA-C, DFAAPAhas worked in multiple medical fields, including emergency medicine and family practice, but has spent the last 20 years as a DermPA™. Over the past decade, she has held key leadership positions, including Secretary-Treasurer for DPAF, Director at large, Secretary/Treasurer, President, immediate Past President of the SDPA. She was awarded the 2024 SDPA Board Member of the Year and board service award.
Laura is a licensed physician assistant, with over 30 years of dedicated service in the medical field, certified by the National Commission on Certification of Physician Assistants (NCCPA). She joined Fayette Area Dermatology in Fayetteville, Georgia in 2007. While Laura started her PA career in emergency medicine and family medicine. At Fayette Area Dermatology, Laura uses her expertise to evaluate and treat dermatologic conditions in patients of all ages and skin types. Her experience includes skin cancers, inflammatory skin conditions, psoriasis, atopic dermatitis, hidradenitis suppurative, keloids, hair loss, rashes, nail disease, pigment disorders, and superficial radiation treatment for cancer.
Laura completed her undergraduate degree at the University of Central Florida, earned a Master of Medical Science from Emory University, and obtained her Doctor of Medical Science from the University of Lynchburg.
